Mon, 7 December 2015
Should Third Generation EGFR Inhibitors Be Used Before First Generation EGFR TKIs or After Progression?
Drs. Leora Horn, Ben Solomon, & Jack West consider whether third generation EGFR TKIs, so active in patients with acquired resistance, might be best used prior to development of acquired resistance.
Direct download: GRACEcast-408_WCLC_2015_Third_Generation_EGFR_Inhibitors_Before_First_Generation_EGFR_TKIs.mp4
Category:Lung-Cancer-Video -- posted at: 2:48pm PDT